IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MARONESE, CARLO ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.982
EU - Europa 2.131
NA - Nord America 1.951
SA - Sud America 356
AF - Africa 72
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.520
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.842
CN - Cina 1.099
SG - Singapore 1.001
IT - Italia 547
DE - Germania 484
BR - Brasile 259
HK - Hong Kong 241
IN - India 181
RU - Federazione Russa 164
ES - Italia 163
GB - Regno Unito 137
SE - Svezia 130
FR - Francia 108
JP - Giappone 98
NL - Olanda 97
VN - Vietnam 74
ID - Indonesia 67
FI - Finlandia 66
TR - Turchia 62
CA - Canada 61
PL - Polonia 46
IE - Irlanda 43
KR - Corea 40
MX - Messico 36
AR - Argentina 34
CI - Costa d'Avorio 32
AT - Austria 26
TW - Taiwan 25
AU - Australia 24
SA - Arabia Saudita 19
BE - Belgio 18
RO - Romania 17
VE - Venezuela 16
CO - Colombia 15
PT - Portogallo 15
GR - Grecia 13
BD - Bangladesh 12
CZ - Repubblica Ceca 12
ZA - Sudafrica 12
CL - Cile 10
IL - Israele 10
IQ - Iraq 10
PE - Perù 9
DK - Danimarca 8
TN - Tunisia 7
UA - Ucraina 7
KE - Kenya 6
EC - Ecuador 5
PH - Filippine 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BY - Bielorussia 4
HR - Croazia 4
PK - Pakistan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
DZ - Algeria 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
PY - Paraguay 3
UY - Uruguay 3
BG - Bulgaria 2
CD - Congo 2
CR - Costa Rica 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
BO - Bolivia 1
BW - Botswana 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HT - Haiti 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PW - Palau 1
Totale 7.516
Salva come PNG Salva come JPEG
Città #
Singapore 452
Ashburn 394
Frankfurt am Main 304
Hefei 251
Dallas 230
Hong Kong 198
Beijing 171
Milan 148
Los Angeles 124
Chandler 120
Bengaluru 89
Santa Clara 79
New York 71
Munich 60
Madrid 56
Council Bluffs 53
Jakarta 52
San Jose 50
Shanghai 48
São Paulo 46
Tokyo 44
Dublin 42
Helsinki 41
Rome 38
Buffalo 34
Guangzhou 33
Abidjan 32
Southend 32
Moscow 28
Ho Chi Minh City 26
Boardman 24
Florence 24
Warsaw 24
Nuremberg 23
Phoenix 23
Barcelona 21
Chennai 21
London 21
Cangzhou 19
Seoul 19
Düsseldorf 18
Princeton 18
Rio de Janeiro 16
Stockholm 16
Montreal 15
Denver 14
Istanbul 14
Lappeenranta 14
Turin 14
Bologna 13
Brooklyn 13
Houston 13
Chengdu 12
Riyadh 12
Berlin 11
Brussels 11
Chicago 11
Fuzhou 11
Izmir 11
Paris 11
Rho 11
Turku 11
Amsterdam 10
Ankara 10
Buenos Aires 10
Hanoi 10
Johannesburg 10
Pune 10
Shenzhen 10
Sydney 10
Toronto 10
Trieste 10
Wuhan 10
Belo Horizonte 9
Brno 9
Hamburg 9
Lauterbourg 9
Melbourne 9
Mexico City 9
Orem 9
Taipei 9
Atlanta 8
Boston 8
Changsha 8
Des Moines 8
Gainesville 8
Hyderabad 8
Las Vegas 8
Padova 8
San Francisco 8
Tianjin 8
Valencia 8
Wroclaw 8
Xi'an 8
Caracas 7
Catania 7
Groningen 7
Islington 7
Lima 7
Nantes 7
Totale 4.183
Salva come PNG Salva come JPEG
Nome #
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 569
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib 547
Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini-melanoma): a retrospective multicentric study of 269 cases 307
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: a case report 238
Dermoscopy of dermal duct tumour 211
Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases 176
Keratosis lichenoides chronica: A case report and focused overview of the literature 168
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy 167
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments 144
Clinical and serological predictors of relapse in pemphigus: a study of 143 patients 142
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease 142
IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab 135
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals 132
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic 129
Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy 125
The Bowel-Associated Arthritis-Dermatosis Syndrome (BADAS): A Systematic Review 125
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 122
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis 115
Persistent variant of acquired verrucous perforating collagenoma 114
Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter" 113
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study 111
Maculopapular rash: An overlooked monkeypox diagnostic clue? 111
Clinical, genetic, and ultrasonographic features of periumbilical perforating pseudoxanthoma elasticum 111
Monkeypox: An Italian, multicentre study of 104 cases 108
Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding 108
Unilesional monkeypox: A report of two cases from Italy 105
Bullous pemphigoid associated with COVID-19 vaccines : An Italian multicentre study 101
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes 100
Indeterminate cell histiocytosis in paediatric population: a review of the literature 100
Primary cutaneous gamma-delta T cell lymphomas: a case series and overview of the literature 96
Extranodal disseminated Rosai-Forfman-destombes disease with cutaneous, articular and cardiac involvement 94
The Intriguing Links between Psoriasis and Bullous Pemphigoid 93
Dermoscopy Use Leads to Earlier Cutaneous Melanoma Diagnosis in Terms of Invasiveness and Size? A Single-Center, Retrospective Experience 90
Pustular psoriasis : from pathophysiology to treatment 90
Eruptive pyogenic granulomas following coronavirus disease 2019 88
The clinical and pathologic spectrum of mucocutaneous reactions after COVID-19 vaccinations in three tertiary referral centers of northern Italy 87
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis 87
Yellowish papules on the palms: a diagnostic challenge 86
COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study 85
Autoinflammation in Syndromic Hidradenitis Suppurativa: The Role of AIM2 85
Syphilis and monkeypox co-infection: Coincidence, synergy or asymptomatic carriage? 85
Generalized eruptive histiocytosis mimicking disseminated molluscum contagiosum: a case report 84
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience 83
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options 82
Faint pigment network in atypical vascular proliferation of the breast: A potential dermoscopic pitfall 81
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors 81
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 77
Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action 76
Brunsting-Perry pemphigoid: a systematic review 76
Different molecular pathways are disrupted in Pyoderma gangrenosum patients and are associated with the severity of the disease 73
Skin manifestations associated with checkpoint inhibitors 71
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 64
Dermoscopy of apocrine adenocarcinoma of the axilla 64
A unique case of steroid-resistant, giant cellulitis-like Sweet syndrome mimicking alpha-1-antitrypsin deficiency-associated panniculitis: successful treatment with dapsone 63
Interleukin-13 in immunohistochemistry: implications for Grover disease, morphea, and immune checkpoint inhibitor-induced bullous pemphigoid 63
Editorial: Cutaneous immunology 62
Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations 61
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 55
IRAK4: A novel target in the therapeutic landscape of hidradenitis suppurativa? 55
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms 53
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response 43
Anal pruritus caused by Dientamoeba fragilis 41
Vitiligo: Unmet Need, Management and Treatment Guidelines 39
Identifying candidates for early intervention in hidradenitis suppurativa 38
Dermoscopy and ultrasonography of Kaposi’s sarcoma nodules: new insights to guide intralesional chemotherapy? 36
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study 33
Urticarial vasculitis following mRNA anti-COVID-19 vaccine 31
Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa? 30
Ultrasonographic diagnosis of erythema nodosum 30
Successful treatment of Hailey-Hailey disease with oral roflumilast 27
Acute generalized exanthematous pustulosis: 15-year retrospective multicenter experience 24
Pyoderma gangrenosum: pathogenetic mechanisms and their implications for treatment 20
Fatal Toxic Epidermal Necrolysis-Like Lupus Erythematosus in a Patient With Metastatic Histiocytic Sarcoma 16
Effectiveness and safety of Tildrakizumab in elderly and frail elderly psoriatic patients up to 2 years 15
What is 'chronic' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment 14
Romosozumab for glucocorticosteroid-induced osteoporosis in patients with autoimmune blistering diseases: primum non nocere 14
Effectiveness of nanofat in treatment-refractory penile lichen sclerosus: results from a pilot retrospective single-center case series 13
Successful Treatment of PAPASH Syndrome With Concomitant FMF Using IL-1 Blockade: A Case Report 12
HIDRADENITIS SUPPURATIVA WITH 20 OR MORE DRAINING TUNNELS: A NATION-WIDE RETROSPECTIVE STUDY 3
Totale 7.745
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.064
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 2 1 7 4 6 15
2021/2022246 2 16 6 4 23 28 17 25 22 15 18 70
2022/2023641 45 58 34 48 70 64 27 63 87 29 86 30
2023/20241.133 40 80 50 105 219 78 89 81 42 86 137 126
2024/20252.195 115 209 114 157 160 103 118 183 118 217 237 464
2025/20263.494 586 578 669 636 542 348 135 0 0 0 0 0
Totale 7.745